News | April 07, 2024
Pluss unveils Celsure XL VIP pallets
A game changing solution for the pharmaceutical industry
A game changing solution for the pharmaceutical industry
Highly effective preservation solutions ensuring the safety and protection of personal care products
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
New leadership team announced at NATHEALTH Annual General Meeting 2024
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
The facility will manufacture tablets, capsules, and injections for the oncology segment
Subscribe To Our Newsletter & Stay Updated
